IRE1/ERN1 (Inositol-Requiring Enzyme 1)

Pathway Diagram

flowchart TD
    ER_Stress["ER Stress"]
    IRE1["IRE1"]
    XBP1["XBP1"]
    ATF4["ATF4"]
    PERK["PERK"]
    JNK["JNK"]
    BBB["Blood-Brain Barrier"]
    Inflammation["Neuroinflammation"]
    IL6["IL6"]
    CXCL1["CXCL1"]
    ALS["ALS"]
    Neurodegeneration["Neurodegeneration"]
    HSPA5["HSPA5"]
    
    ER_Stress -->|"activates"| IRE1
    IRE1 -->|"splices"| XBP1
    IRE1 -->|"activates"| ATF4
    IRE1 -->|"cross-talk"| PERK
    IRE1 -->|"phosphorylates"| JNK
    IRE1 -->|"disrupts"| BBB
    IRE1 -->|"promotes"| Inflammation
    IRE1 -->|"upregulates"| HSPA5
    Inflammation -->|"secretes"| IL6
    Inflammation -->|"secretes"| CXCL1
    JNK -->|"drives"| Neurodegeneration
    BBB -->|"contributes"| ALS
    ALS -->|"leads to"| Neurodegeneration
    
    classDef central fill:#006494
    classDef protective fill:#1b5e20
    classDef pathological fill:#ef5350
    classDef regulatory fill:#4a1a6b
    classDef outcome fill:#5d4400
    
    class IRE1 central
    class XBP1,ATF4,HSPA5 protective
    class JNK,BBB,Inflammation,IL6,CXCL1 pathological
    class PERK regulatory
    class ALS,Neurodegeneration outcome

Overview

Inositol-requiring enzyme 1 (IRE1) is the most evolutionarily conserved sensor of the unfolded protein response (UPR). As a dual kinase/endoribonuclease, IRE1 transduces ER stress signals through both enzymatic activities: its kinase domain initiates signaling cascades while its RNase domain splices XBP1 mRNA to activate adaptive gene expression programs.

Structure

IRE1 is a type I transmembrane protein with distinct functional domains:

• N-terminal luminal domain: Senses unfolded proteins in the ER lumen

• Transmembrane domain: Anchors protein in ER membrane

• Cytoplasmic kinase domain: Serine/threonine kinase activity

• Cytoplasmic RNase domain: Endoribonuclease activity

• C-terminal tail: Regulatory region

Under ER stress, IRE1 oligomerizes into higher-order complexes that activate both enzymatic functions.

Normal Function

ER Stress Sensing

IRE1 monitors ER protein folding capacity:

1. Basal state: Bound to BiP/GRP78, inactive monomer

2. ER stress: Unfolded proteins compete for BiP binding

3. Activation: IRE1 dimerizes and oligomerizes

4. Signaling: Initiates UPR adaptive responses

XBP1 Splicing

The canonical IRE1 output is XBP1 mRNA splicing:

• Unconventional splicing: Cleaves at specific stem-loops

• XBP1s production: Spliced mRNA encodes active transcription factor

• Adaptive genes: Chaperones, ERAD components, lipid synthesis

Regulated IRE1-Dependent Decay (RIDD)

Under prolonged stress, IRE1 degrades mRNAs:

• Substrate selection: Specific sequence motifs

• Outcomes: Reduces protein load, can promote apoptosis

• Cell fate decision: Adaptive vs. terminal UPR

Kinase Signaling

The kinase domain activates additional pathways:

• JNK activation: Through TRAF2-ASK1 cascade

• NF-kB signaling: Inflammatory responses

• Autophagy regulation: Through multiple mechanisms

Role in Neurodegeneration

Alzheimer’s Disease

IRE1 signaling is chronically activated in AD:

1. Abeta-induced ER stress: Secretase processing generates stress

2. Sustained IRE1 activation: Chronic UPR in neurons

3. RIDD activation: Degrades protective mRNAs

4. XBP1 dysfunction: Impaired adaptive response

Studies show:

• Increased IRE1 phosphorylation in AD brains

• XBP1 target genes dysregulated

• RIDD contributes to synaptic loss

Parkinson’s Disease

ER stress from protein aggregation:

• alpha-synuclein toxicity: Aggregates cause ER stress

• CHOP induction: Pro-apoptotic UPR output

• Mitochondria-ER crosstalk: MAM disruption

• IRE1-JNK signaling: Promotes neuronal death

ALS/FTD

Motor neuron vulnerability to ER stress:

• TDP-43 aggregation: ER stress induction

• SOD1 mutants: Chronic ER stress in ALS models

• C9orf72: Dipeptide repeats cause ER stress

• XBP1 splicing: Impaired in ALS motor neurons

Huntington’s Disease

Polyglutamine aggregation and ER stress:

• mHTT aggregates: Impair ER function

• UPR activation: Chronic IRE1 signaling

• Synaptic dysfunction: RIDD degrades synaptic mRNAs

• Cell death: Terminal UPR contributes to loss

Prion Diseases

Prion protein misfolding:

• ER retention: Misfolded PrP causes stress

• IRE1 activation: Early disease marker

• Neuroprotective XBP1: May delay onset

Therapeutic Targeting

IRE1 Inhibitors

Compounds targeting IRE1 activity:

1. Kinase inhibitors: KIRA6, KIRA8 (allosteric)

2. RNase inhibitors: 4mu8c, STF-083010

3. Dual inhibitors: Target both activities

4. Selective modulation: Context-dependent effects

XBP1 Activation

Boosting adaptive UPR:

• XBP1 gene therapy: AAV delivery to neurons

• Small molecule splicing: Promote XBP1s production

• Downstream targets: Enhance chaperone expression

Combination Approaches

Multi-target UPR modulation:

• PERK + IRE1: Balance adaptive vs. terminal

• ATF6 + IRE1: Synergistic chaperone induction

• Chaperone therapy: Complement UPR enhancement

Clinical Development

IRE1-targeted therapies in development:

• KIRA compounds: Preclinical neuroprotection

• XBP1 modulators: Early-stage development

• Biomarker development: UPR signatures in CSF

Key Interactions

See Also

• tau-protein — Related tau kinase substrate in AD

• amyloid-beta — Related APP cleavage product

• GSK3B — Major kinase in neurodegeneration

• CDK5 — Another tau kinase

• BACE1 — Beta-secretase in amyloidogenesis

External Links

• UniProt - Protein sequence and functional data

• PubMed - Biomedical literature

• PDB - Protein structure data